We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Automated Leucocyte VCS Parameters Evaluated for Pathogenic Infections

By LabMedica International staff writers
Posted on 16 Feb 2021
Malaria and dengue are highly endemic in most parts of India. More...
Mangalore, a city in coastal Karnataka, India, has high prevalence of both these vector‐borne infections with extensive range of clinical presentations. The outbreak of these infections is common during and after the rainy season.

Clinical symptoms of these infections intersect each other and those seen in leptospirosis, typhoid fever and rickettsial infections. The latter three, though not as common as malaria and dengue fever, pose diagnostic difficulties in their early phases. The clinical presentation can vary from a mild febrile illness to lethal complications such as disseminated intravascular coagulation.

Medical Laboratory Scientists at the Kasturba Medical College (Manipal, India) compared automated parameters by VCS technology that can predict and aid in rapid and reliable prediction of specific infections such as malaria, dengue, leptospirosis, typhoid and rickettsial infections. This technology quantifies volume of the cells by voltage impedance (V); nuclear‐cytoplasmic ratio by radiofrequency conductivity (C); and internal cellular features such as cytoplasmic granularity and nuclear complexity by laser light scatter (S) and hence known as VCS technology. A total of 324 patients fulfilled the inclusion criteria of infection group and equal number of controls were included in the study.

The scientists used the Coulter DXH800 hematology analyzer (Beckman Coulter Inc., Miami, FL, USA). Serologically positive cases of dengue, leptospirosis, typhoid and rickettsia; and malaria cases diagnosed by florescence microscopy‐ quantitative buffy coat (QBC) method and were confirmed by peripheral smear examination. The dengue cases were taken as positive based on positivity using either dengue NS1 test (immunochromatography card) or dengue IgM Panbio ELISA, and the leptospirosis cases were considered positive based on IgM Panbio ELISA test (Panbio Inc. Brisbane, Australia).

The team reported that a total of 324 cases comprising of malaria (50%), dengue (30.9%), leptospirosis (13.9%), typhoid (4.0%) and rickettsial infections (1.2%) were included. There was statistically significant differences in the mean values of complete blood count parameters—hemoglobin, total leucocyte count, red blood cell count, hematocrits, red cell distribution width, differential leucocyte count, platelet count and plateletcrit between cases and controls and also between specific infections. The mean volumes of neutrophil, monocyte and lymphocyte were considerably increased in malaria and dengue fever compared to leptospirosis, typhoid and rickettsial infections. VCS parameters were the least altered in typhoid fever, except for a strikingly high conductivity and scatter of eosinophils.

The authors concluded that there was significant difference in the volume, conductivity and scatter of neutrophils, monocytes and lymphocytes between the five groups and the values are found to be greatest in malaria. Mean neutrophil volume (MNV), mean lymphocyte volume (MLV) and mean monocyte volume (MMV) were increased significantly in malaria and dengue fever compared to leptospirosis, typhoid and rickettsial infections. Dengue cases showed significantly higher values in most of the leucocyte light scatter data. The study was published on February 4, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
Kasturba Medical College
Beckman Coulter Inc
Panbio Inc



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Mpox Analysis Reveals Substantial Suspected False Positives Associated with Contamination

Reliable confirmation of mpox can be difficult where multiple rash-causing illnesses co-circulate and laboratory capacity is limited. Although PCR is central to case detection, contamination during specimen... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.